Table 3.
Baseline mean anthropometric and blood measurements by group
| |
|
Waitlisted N=49 |
Active N=51 |
||
|---|---|---|---|---|---|
| Mean | 95% CI | Mean | 95% CI | ||
| Age |
Age (years) |
40.7 |
37.7-43.6 |
39.8 |
36.7-43.1 |
| Anthropometrics |
Height (m) |
1.62 |
1.61-1.64 |
1.61 |
1.60-1.62 |
| |
Weight (kg) |
88.8 |
82.8-94.8 |
94.0 |
88.1-99.9 |
| |
BMI (kg/m2) |
33.5 |
31.5-35.6 |
36.1 |
34.0-38.2 |
| |
Waist (cm) |
101.5 |
97.0-106.0 |
104.2 |
100.0-108.3 |
| |
Hip (cm) |
117.0 |
112.3-121.7 |
120.6 |
115.9-125.2 |
| |
Waist to Hip Ratio |
0.87 |
0.85-0.89 |
0.87 |
0.85-0.88 |
| Blood Pressure |
Systolic BP (mmHg) |
129.5 |
124.1-135.0 |
129.4 |
125.4-133.4 |
| |
Diastolic BP (mmHg) |
87.5 |
83.9-91.1 |
88.3 |
85.3-91.3 |
| Pathology |
Glucose (mmol/L) |
6.4 |
5.1-7.7 |
5.6 |
4.9-6.3 |
| |
Insulin (mU/L) |
17.4 |
14.1-20.7 |
17.5 |
14.7-20.2 |
| |
HbA1c (%) |
6.5 |
6.0-7.1 |
6.1 |
5.7-6.4 |
| |
Cholesterol (mmol/L) |
4.6 |
4.3-5.0 |
4.9 |
4.6-5.2 |
| |
Triglycerides (mmol/L) |
1.5 |
1.1-1.8 |
1.5 |
1.3-1.7 |
| |
LDL (mmol/L) |
2.8 |
2.4-3.0 |
3.0 |
2.8-3.2 |
| |
HDL (mmol/L) |
1.2 |
1.1-1.3 |
1.2 |
1.1-1.3 |
| |
LDL:HDL |
2.4* |
2.1-2.7 |
2.6 |
2.3-2.9 |
| |
Cholesterol:HDL |
4.1 |
3.6-4.5 |
4.2 |
3.8-4.5 |
| |
CRP (mg/L) |
7.2 |
4.4-10.0 |
7.5# |
5.6-9.4 |
| Calculated HOMA-IR | HOMA-IR | 5.3 | 3.4-7.2 | 4.3 | 3.6-5.1 |
The observations for blood pressure were reduced due to missing data; waitlisted participants n=45, active participants n=49. The observations for pathology results were reduced due to missing data; waitlisted participants n=29, active participants n=44.
* Observation reduced by one. LDL value missing – invalid as triglyceride concentration was > 4.5 mmol/L.
# Observation reduced by one. CRP was > 100 mg/L indicating bacterial infection.
Abbreviations: CI = confidence intervals; BMI = body mass index; Waist = waist circumference; Hip = hip circumference; HbA1C = glycated haemoglobin; LDL = low-density lipoprotein; HDL = high-density lipoprotein; CRP = C-reactive protein; HOMA-IR = Homeostatic model assessment for insulin resistance.